Connection
David Keller to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications David Keller has written about Antibodies, Monoclonal, Humanized.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.084 |
|
|
|
-
Sopata M, Katz N, Carey W, Smith MD, Keller D, Verburg KM, West CR, Wolfram G, Brown MT. Efficacy and safety of tanezumab in the treatment of pain from bone metastases. Pain. 2015 Sep; 156(9):1703-1713.
Score: 0.084